Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program

Summary

105 infertile women are enrolled in the randomized controlled trial: 70 women with a history of RIF with donated oocytes and 35 infertile women undergoing the first oocyte donation attempt. Women receiving donated oocytes are treated with progressively increasing doses of oral estradiol followed by intravaginal progesterone after previous pituitary desensitization with GnRH agonist. 35 RIF patients are treated with GH (GH patients) while the rest 35 RIF patients (non-GH patients) and 35 first-attempt patients (positive control group) are not.

Timeline

Start

2010-01-01

Primary completion

2017-12-31

Completion

2017-12-31

Drugs

Indications